Current status of hepatocyte xenotransplantation

Allen, 2001, Liver cell transplantation: the road to clinical application, J. Lab. Clin. Med., 138, 298, 10.1067/mlc.2001.119148 Vogel, 2014, Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects, J. Inherit. Metab. Dis., 37, 165, 10.1007/s10545-013-9656-5 Sokal, 2006, Liver transplantation for inborn errors of liver metabolism, J. Inherit. Metab. Dis., 29, 426, 10.1007/s10545-006-0288-x Strom, 1999, Hepatocyte transplantation for the treatment of human disease, Semin. Liver Dis., 19, 39, 10.1055/s-2007-1007096 Strom, 1997, Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure, Transplantation, 63, 559, 10.1097/00007890-199702270-00014 Soucek, 2001, Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs, BMC Pharmacol., 1, 11, 10.1186/1471-2210-1-11 Ekser, 2012, Comparison of hematologic, biochemical, and coagulation parameters in alpha1,3-galactosyltransferase gene-knockout pigs, wild-type pigs, and four primate species, Xenotransplantation, 19, 342, 10.1111/xen.12007 Kobayashi, 1998, Comparison of bile chemistry between humans, baboons, and pigs: implications for clinical and experimental liver xenotransplantation, Lab. Anim. Sci., 48, 197 Cattan, 1996, Comparison between aortic and sinusoidal liver endothelial cells as targets of hyperacute xenogeneic rejection in the pig to human combination, Transplantation, 62, 803, 10.1097/00007890-199609270-00018 Zhou, 2015, Experimental hepatocyte xenotransplantation-a comprehensive review of the literature, Xenotransplantation, 22, 239, 10.1111/xen.12170 Koch, 2005, Intrinsic resistance of hepatocytes to complement-mediated injury, J. Immunol., 174, 7302, 10.4049/jimmunol.174.11.7302 Hara, 2008, In vitro investigation of pig cells for resistance to human antibody-mediated rejection, Transpl. Int., 21, 1163, 10.1111/j.1432-2277.2008.00736.x Rhim, 1995, Complete reconstitution of mouse liver with xenogeneic hepatocytes, Proc. Natl. Acad. Sci. U. S. A., 92, 4942, 10.1073/pnas.92.11.4942 Arkadopoulos, 1998, Intrasplenic transplantation of allogeneic hepatocytes prolongs survival in anhepatic rats, Hepatology, 28, 1365, 10.1002/hep.510280527 Ahmad, 2002, Role of intrasplenic hepatocyte transplantation in improving survival and liver regeneration after hepatic resection in cirrhotic rats, Cell Transpl., 11, 399, 10.3727/000000002783985729 Andreoletti, 2001, Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates: implication for ex vivo gene therapy, Hum. Gene Ther., 12, 169, 10.1089/104303401750061230 Vons, 2001, Transplantation of hepatocytes in nonhuman primates: a preclinical model for the treatment of hepatic metabolic diseases, Transplantation, 72, 811, 10.1097/00007890-200109150-00012 Nagata, 2007, Prolonged survival of porcine hepatocytes in cynomolgus monkeys, Gastroenterology, 132, 321, 10.1053/j.gastro.2006.10.013 Sgroi, 2009, What clinical alternatives to whole liver transplantation? current status of artificial devices and hepatocyte transplantation, Transplantation, 87, 457, 10.1097/TP.0b013e3181963ad3 Hughes, 2012, Current status of hepatocyte transplantation, Transplantation, 93, 342, 10.1097/TP.0b013e31823b72d6 Yeh, 2014, Increased transfusion-free survival following auxiliary pig liver xenotransplantation, Xenotransplantation, 21, 454, 10.1111/xen.12111 Ekser, 2012, Genetically-engineered pig-to-baboon liver xenotransplantation: histopathology of xenografts and native organs, PloS One, 7, e29720, 10.1371/journal.pone.0029720 Griesemer, 2014, Xenotransplantation: immunological hurdles and progress toward tolerance, Immunol. Rev., 258, 241, 10.1111/imr.12152 Samy, 2014, islet cell xenotransplantation: a serious look towards the clinic, Xenotransplantation, 21, 221, 10.1111/xen.12095 Van de Kerkhove, 2005, Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems, J. Hepatol., 42, 541, 10.1016/j.jhep.2004.11.041 Nagata, 2003, Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation, Gastroenterology, 124, 422, 10.1053/gast.2003.50065 Yamamoto, 2010, Treatment of acute liver failure in mice by hepatocyte xenotransplantation, Cell Transpl., 19, 799, 10.3727/096368910X508915 Mai, 2005, Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes, Xenotransplantation, 12, 457, 10.1111/j.1399-3089.2005.00248.x Mei, 2009, Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice, Cell Transpl., 18, 101, 10.3727/096368909788237168 Navarro-Alvarez, 2011, CD47: a new player in phagocytosis and xenograft rejection, Cell. Mol. Immunol., 8, 10.1038/cmi.2010.83 Navarro-Alvarez, 2014, Lack of CD47 on donor hepatocytes promotes innate immune cell activation and graft loss: a potential barrier to hepatocyte xenotransplantation, Cell Transpl., 23, 345, 10.3727/096368913X663604 Waern, 2012, Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice, Hepatology, 56, 1479, 10.1002/hep.25816 Morosan, 2006, Liver-stage development of Plasmodium falciparum, in a humanized mouse model, J. Infect. Dis., 193, 996, 10.1086/500840 Strick-Marchand, 2015, A novel mouse model for stable engraftment of a human immune system and human hepatocytes,, PloS One, 10, e0119820, 10.1371/journal.pone.0119820 Baumann, 2004, Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity, J. Immunol., 172, 6460, 10.4049/jimmunol.172.10.6460 Kawahara, 2010, Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice, Transpl. Int., 23, 934 Ramackers, 2014, Species-specific regulation of fibrinogen synthesis with implications for porcine hepatocyte xenotransplantation, Xenotransplantation, 21, 444, 10.1111/xen.12110 Kleine, 2008, Clinical versatility of porcine hepatocytes in the light of interspecies differences in cytochrome P450 regulation and expression, Xenotransplantation, 15, 208, 10.1111/j.1399-3089.2008.00478.x Schrem, 2006, Physiological incompatibilities of porcine hepatocytes for clinical liver support, Liver Transpl., 12, 1832, 10.1002/lt.20918 Stravitz, 2013, Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure, Hepatology, 58, 304, 10.1002/hep.26307 Rabanel, 2009, Progress technology in microencapsulation methods for cell therapy, Biotechnol. Prog., 25, 946, 10.1002/btpr.226 Kang, 2014, Cell encapsulation via microtechnologies, Biomaterials, 35, 10.1016/j.biomaterials.2013.12.073 Acarregui, 2013, Therapeutic applications of encapsulated cells, Methods Mol. Biol., 1051, 349, 10.1007/978-1-62703-550-7_23 Mahou, 2010, Alginate-poly(ethylene glycol) hybrid microspheres with adjustable physical properties, Macromolecules, 43, 1371, 10.1021/ma902469f Rokstad, 2011, Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model, Acta Biomater., 7, 2566, 10.1016/j.actbio.2011.03.011 Meier, 2014, Survival of free and encapsulated human and rat islet xenografts transplanted into the mouse bone marrow, PloS One, 9, e91268, 10.1371/journal.pone.0091268 Mahou, 2014, Alginate-poly(ethylene glycol) hybrid microspheres for primary cell microencapsulation, Materials, 7, 275, 10.3390/ma7010275 Zekorn, 1992, Barium-cross-linked alginate beads - a simple, one-step method for successful immunoisolated transplantation of islets of Langerhans, Acta Diabetol., 29, 99, 10.1007/BF00572552 Thanos, 2007, Formulating the alginate-polyornithine biocapsule for prolonged stability: evaluation of composition and manufacturing technique, J. Biomed. Mater. Res. A, 83, 216, 10.1002/jbm.a.31472 Luna, 2010, Development of a novel cell encapsulation system based on natural origin polymers for tissue engineering applications, J. Bioact. Compat. Polym., 25, 341, 10.1177/0883911510372173 Mazumder, 2009, Core-cross-linked alginate microcapsules for cell encapsulation, Biomacromolecules, 10, 1365, 10.1021/bm801330j Sawhney, 1992, Poly(ethylene oxide)-graft-poly(L-lysine) copolymers to enhance the biocompatibility of poly(L-lysine)-alginate microcapsule membranes, Biomaterials, 13, 863, 10.1016/0142-9612(92)90180-V Luan, 2010, Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation, Biomaterials, 31, 8847, 10.1016/j.biomaterials.2010.08.004 Stiegler, 2010, Creation of a prevascularized site for cell transplantation in rats, Xenotransplantation, 17, 379, 10.1111/j.1399-3089.2010.00606.x Davidovich-Pinhas, 2011, Physical and structural characteristics of acrylated poly(ethylene glycol)-alginate conjugates, Acta Biomater., 7, 2817, 10.1016/j.actbio.2011.04.001 Giovagnoli, 2010, Bioactive long-term release from biodegradable microspheres preserves implanted ALG-PLO-ALG microcapsules from in vivo response to purified alginate, Pharm. Res., 27, 285, 10.1007/s11095-009-0017-x Babister, 2008, Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using “bead-in-bead” polysaccharide capsules, Biomaterials, 29, 58, 10.1016/j.biomaterials.2007.09.006 De Castro, 2009, Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules, J. Biomed. Mater. Res. A, 15, 1119, 10.1002/jbm.a.32270 Mahou, 2013, Combined electrostatic and covalent polymer networks for cell microencapsulation, Macromol. Symp., 329, 49, 10.1002/masy.201200099 Meier, 2015, Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice, J. Hepatol., 62, 634, 10.1016/j.jhep.2014.10.030 Tomei, 2014, Device design and materials optimization of conformal coating for islets of Langerhans, Proc. Natl. Acad. Sci. U. S. A., 111, 10514, 10.1073/pnas.1402216111 Gomez, 1997, Evidence for survival and metabolic activity of encapsulated xenogeneic hepatocytes transplanted without immunosuppression in Gunn rats, Transplantation, 63, 1718, 10.1097/00007890-199706270-00003 Roger, 1998, Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study, Ann. Surg., 228, 1, 10.1097/00000658-199807000-00001 Sgroi, 2011, Transplantation of encapsulated hepatocytes during acute liver failure improves survival without stimulating native liver regeneration, Cell Transpl., 20, 1791, 10.3727/096368911X564976 Jitraruch, 2014, Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure, PLoS One, 9, e113609, 10.1371/journal.pone.0113609 Polson, 2005, AASLD position paper: the management of acute liver failure, Hepatology, 41, 1179, 10.1002/hep.20703 Safety and efficacy of ELAD to treat acute liver failure (ALF), https://www.clinicaltrials.gov/ct2/show/NCT01875874?term=ELAD&rank=4. (accessed 12.07.15). Study to assess safety and efficacy of ELAD in subjects with severe acute alcoholic hepatitis (sAAH) and Lille score failure, https://www.clinicaltrials.gov/ct2/show/NCT01829347?term=ELAD&rank=5. (accessed 12.07.15). Schuurman, 2009, The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes–chapter 2: source pigs,, Xenotransplantation, 16, 215, 10.1111/j.1399-3089.2009.00541.x